Japan Tissue Engineering Co., Ltd.

TSE:7774 Stock Report

Market Cap: JP¥26.8b

Japan Tissue Engineering Future Growth

Future criteria checks 5/6

Japan Tissue Engineering is forecast to grow earnings and revenue by 219.4% and 50% per annum respectively while EPS is expected to grow by 219.7% per annum.

Key information

219.4%

Earnings growth rate

219.7%

EPS growth rate

Biotechs earnings growth31.0%
Revenue growth rate50.0%
Future return on equityn/a
Analyst coverage

Low

Last updated30 Jan 2024

Recent future growth updates

Recent updates

The Market Lifts Japan Tissue Engineering Co., Ltd. (TSE:7774) Shares 35% But It Can Do More

Mar 06
The Market Lifts Japan Tissue Engineering Co., Ltd. (TSE:7774) Shares 35% But It Can Do More

We Think Japan Tissue Engineering (TYO:7774) Can Afford To Drive Business Growth

Feb 02
We Think Japan Tissue Engineering (TYO:7774) Can Afford To Drive Business Growth

Earnings and Revenue Growth Forecasts

TSE:7774 - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20254,393959N/AN/A1
3/31/20242,83295N/AN/A1
12/31/20232,374-157N/AN/AN/A
9/30/20232,306-319-291-139N/A
6/30/20232,272-448N/AN/AN/A
3/31/20232,032-729-797-622N/A
12/31/20221,951-782N/AN/AN/A
9/30/20222,095-651-668-468N/A
6/30/20222,047-636N/AN/AN/A
3/31/20222,103-497-342-225N/A
12/31/20212,469-396N/AN/AN/A
9/30/20212,321-461-342-275N/A
6/30/20212,358-421N/AN/AN/A
3/31/20212,257-466-473-399N/A
12/31/20202,187-335N/AN/AN/A
9/30/20202,242-288-299-229N/A
6/30/20202,253-277N/AN/AN/A
3/31/20202,309-287-175-84N/A
12/31/20192,325-210N/AN/AN/A
9/30/20192,317-189-211-77N/A
6/30/20192,366-77N/AN/AN/A
3/31/20192,357-333-468-396N/A
12/31/20182,199-364N/AN/AN/A
9/30/20182,204-255-212-184N/A
6/30/20182,188-216N/AN/AN/A
3/31/20182,271227601632N/A
12/31/20172,590585N/AN/AN/A
9/30/20172,459507N/A544N/A
6/30/20172,282401N/AN/AN/A
3/31/20172,135276N/A54N/A
12/31/20161,628-165N/AN/AN/A
9/30/20161,500-405N/A-314N/A
6/30/20161,470-567N/AN/AN/A
3/31/20161,430-681N/A-346N/A
12/31/20151,431-651N/AN/AN/A
9/30/20151,503-600N/A-587N/A
6/30/20151,343-713N/AN/AN/A
3/31/20151,321-690N/A-756N/A
12/31/20141,177-833N/AN/AN/A
9/30/20141,103-861N/A-755N/A
6/30/20141,083-815N/AN/AN/A
3/31/20141,008-827N/A-961N/A
12/31/2013847-996N/AN/AN/A
9/30/2013740-1,022N/A-918N/A
6/30/2013692-996N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 7774 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).

Earnings vs Market: 7774 is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: 7774 is expected to become profitable in the next 3 years.

Revenue vs Market: 7774's revenue (50% per year) is forecast to grow faster than the JP market (4.4% per year).

High Growth Revenue: 7774's revenue (50% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 7774's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.